Radiosynthesis of no-carrier-added meta-[124I] iodobenzylguanidine for PET imaging of metastatic neuroblastoma

Autor: Gavin Brown, Nigel Westwood, Michael Green, Sue Siew Chen Chua, Jonathan Lowe, Adam McMahon, Manikandan Kadirvel
Jazyk: angličtina
Rok vydání: 2017
Předmět:
Zdroj: Green, M, Lowe, J, Kadirvel, M, Mcmahon, A, Westwood, N, Chua, S S C & Brown, G 2017, ' Radiosynthesis of no-carrier-added meta-[124I] iodobenzylguanidine for PET imaging of metastatic neuroblastoma ' Journal of Radioanalytical and Nuclear Chemistry, vol 311, no. 1 . DOI: 10.1007/s10967-016-5073-1
Green, M, Lowe, J, Kadirvel, M, Mcmahon, A, Westwood, N, Chua, S S C & Brown, G 2017, ' Radiosynthesis of no-carrier-added meta-[124I] iodobenzylguanidine for PET imaging of metastatic neuroblastoma ', Journal of Radioanalytical and Nuclear Chemistry, vol. 311, no. 1 . https://doi.org/10.1007/s10967-016-5073-1
DOI: 10.1007/s10967-016-5073-1
Popis: Meta-iodobenzylguanidine (mIBG) has been radiolabelled at the no-carrier-added level with [124I] for a proof of concept study to assess the diagnostic accuracy of [124I]mIBG PET/CT in detecting metastatic deposits in patients diagnosed with metastatic neuroblastoma. Radiolabelling of mIBG was achieved via the iododesilylation reaction between [124I]sodium iodide and meta-trimethylsilylbenzylguanidine. [124I]mIBG was produced in 62–70 % radioiodide incorporation yield from [124I]sodium iodide. The average amount of formulated [124I]mIBG was 359 MBq (range 344–389 MBq) with an average specific radioactivity of 4.1 TBq μmol−1 (range 1.8–5.9 TBq μmol−1) at end of synthesis.
Databáze: OpenAIRE